CancerVax
CancerVax
CancerVax (pronounced: /ˈkænsərvæks/) is a biopharmaceutical company that focuses on the research, development, and commercialization of novel biological products for the treatment and prevention of cancer.
Etymology
The term "CancerVax" is a combination of the words "Cancer" and "Vax", short for vaccine. The name reflects the company's primary focus on developing vaccines for cancer treatment.
History
CancerVax was founded in 1999 with the aim of developing and commercializing novel biological products for the treatment and prevention of cancer. The company's approach is based on the use of immunotherapy, a type of treatment that uses the body's own immune system to fight cancer.
Products
CancerVax's product portfolio includes a range of cancer vaccines and immunotherapies. These products are designed to stimulate the immune system to recognize and destroy cancer cells.
Related Terms
- Cancer: A group of diseases characterized by the uncontrolled growth and spread of abnormal cells.
- Immunotherapy: A type of cancer treatment that uses the body's immune system to fight cancer.
- Cancer vaccine: A type of treatment that uses a substance to stimulate the immune system to destroy cancer cells.
External links
- Medical encyclopedia article on CancerVax
- Wikipedia's article - CancerVax
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski